CONMED Secures $450M Delayed-Draw Term Loan to Repurchase Convertible Notes
CNMD is trading near its 52-week low of $33.21 (7.5% above the low).
Summary
CONMED Corporation has secured a $450 million delayed-draw term loan facility to repurchase a portion of its 2.25% Convertible Senior Notes due 2026, enhancing its debt management strategy.
Key Events · Financing and Capital Events · CNMD
-
New Credit Facility Established
CONMED entered into the First Omnibus Amendment and Increased Facility Activation Notice, establishing a $450 million senior secured delayed-draw Term A-2 Loan Facility.
-
Debt Repurchase Strategy
The proceeds from this new facility are specifically designated to repurchase a portion of CONMED's outstanding 2.25% Convertible Senior Notes due 2026.
-
Maturity Profile Extended
The Term A-2 Loan Facility matures on June 10, 2030, aligning with the maturity date of the company's existing revolving and term loan facilities.
Analysis · CNMD · Industrial Applications And Services
This filing details CONMED's proactive debt management by securing a substantial $450 million delayed-draw term loan. This facility is specifically intended to repurchase a portion of the company's 2.25% Convertible Senior Notes due 2026, addressing a significant near-term maturity. The new loan, which is senior secured and matures in 2030, provides financial flexibility and reduces refinancing risk for the company. This follows the recent 10-Q filing which highlighted the $800 million convertible debt.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 36.1% of the 1051 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.56%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CNMD was trading at $35.70 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.1B. The 52-week trading range was $33.21 to $60.35. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.